{"public_id":"cl_75a60bc6f4240b0a00863737b44708bd","status":"active","superseded_by_public_id":null,"corpus_id":23287854,"text":"Continuous insulin infusion increased intravenous glucose tolerance in extremely premature very low birth weight infants, raising tolerated glucose delivery over the first 72 hours.","confidence":0.98,"paper":{"corpus_id":23287854,"title":"Continuous Insulin Infusion in Hyperglycemic, Very Low Birth Weight Infants","url":"https://sah.borca.ai/papers/23287854"},"contributors":[{"id":391,"public_id":"x53qfq3ny9","public_label":"kafkapple (x53qfq3ny9)","roles":["extraction"],"url":"https://sah.borca.ai/u/x53qfq3ny9"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.98,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_526c3ce02e505f64ce63a866276468d7","name":"continuous insulin infusion","description":"A treatment strategy that delivers insulin continuously by infusion.","types":["treatment"],"url":"https://sah.borca.ai/concepts/co_526c3ce02e505f64ce63a866276468d7"},{"public_id":"co_5f1cead407b893566be03a4ea2c8ca12","name":"intravenous glucose","description":"Glucose administered through an intravenous line as part of nutritional support.","types":["intervention"],"url":"https://sah.borca.ai/concepts/co_5f1cead407b893566be03a4ea2c8ca12"},{"public_id":"co_bf7b3e3656e1b616d6eddf03fe538c89","name":"intravenous glucose tolerance","description":"The capacity to receive and use glucose delivered intravenously.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_bf7b3e3656e1b616d6eddf03fe538c89"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_75a60bc6f4240b0a00863737b44708bd"}